PNC Financial Services Group
ARQT icon

PNC Financial Services Group’s Arcutis Biotherapeutics ARQT Stock Holding History

PNC Financial Services Group’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
21,105
+3,508
+20% +$81.7K ﹤0.01% 1719
2026
Q1 		$415K Buy
17,597
+4,000
+29% +$102K ﹤0.01% 1816
2025
Q4 		$395K Buy
13,597
+4,991
+58% +$128K ﹤0.01% 1840
2025
Q3 		$162K Sell
8,606
-222
-3% -$3.5K ﹤0.01% 2439
2025
Q2 		$124K Buy
8,828
+820
+10% +$11.5K ﹤0.01% 2558
2025
Q1 		$125K Sell
8,008
-263
-3% -$3.71K ﹤0.01% 2515
2024
Q4 		$115K Sell
8,271
-1,648
-17% -$18.1K ﹤0.01% 2597
2024
Q3 		$92.2K Buy
9,919
+188
+2% +$1.85K ﹤0.01% 2714
2024
Q2 		$90.5K Sell
9,731
-33
-0.3% -$298 ﹤0.01% 2694
2024
Q1 		$96.8K Buy
9,764
+241
+3% +$1.8K ﹤0.01% 2633
2023
Q4 		$30.8K Buy
9,523
+539
+6% +$1.47K ﹤0.01% 3210
2023
Q3 		$47.7K Sell
8,984
-831
-8% -$7.07K ﹤0.01% 2984
2023
Q2 		$93.5K Buy
9,815
+1,598
+19% +$17.7K ﹤0.01% 2682
2023
Q1 		$90.4K Sell
8,217
-5,763
-41% -$83.4K ﹤0.01% 2626
2022
Q4 		$207K Buy
13,980
+4,415
+46% +$77.1K ﹤0.01% 2102
2022
Q3 		$183K Buy
9,565
+6,917
+261% +$157K ﹤0.01% 2146
2022
Q2 		$56K Buy
+2,648
New +$54.3K ﹤0.01% 2916
2021
Q4 		– Sell
-1,500
Closed -$36K – 4436
2021
Q3 		$36K Hold
1,500
– – ﹤0.01% 3246
2021
Q2 		$40K Buy
+1,500
New +$42.3K ﹤0.01% 3181

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PNC Financial Services Group's ARQT Position: Q2 2026 in Review

PNC Financial Services Group increased its Arcutis Biotherapeutics (ARQT) stake by 20% in Q2 2026, buying an estimated $81.7K and bringing the position to 21,105 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

PNC Financial Services Group first reported a position in ARQT in Q2 2021 and has held it in 19 quarters since. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • PNC Financial Services Group held 21,105 shares of Arcutis Biotherapeutics worth $553K as of Q2 2026.
  • PNC Financial Services Group bought 3,508 Arcutis Biotherapeutics shares in Q2 2026, an estimated $81.7K.
  • Arcutis Biotherapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1719 holding.
  • PNC Financial Services Group first reported a position in Arcutis Biotherapeutics in Q2 2021 and has held it in 19 quarters since.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.